Gasparro et al. showed that PSMA PET/CT detected more metastases than conventional imaging in four patients, and the mean SUVmax for metastatic RCC lesions ranged from vascular (11.8) to liver (29.8). This evidence concerns the gene FOLH1 and renal cell carcinoma.